Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Dragan Urosevic
Observed names:
D Urosevic,
D. Urosevic,
Urosevic Dragan
Institution:
Sandoz Group AG (Switzerland)
Observed institutions:
F. Hoffmann-La Roche AG,
Novartis (Switzerland),
Inserm,
Sandoz Group AG (Switzerland),
Novartis Institutes for BioMedical Research,
Université de Strasbourg
show all 6
OpenAlex ID:
A5070789193
IRAS, the human homologue of Nischarin, prolongs survival of transfected PC12 cells
2003
·
M Dontenwill
, G Pascal
, et al.
·
Cell Death and Differentiation
·
34
[125I]2-(2-Chloro-4-iodo-phenylamino)-5-methyl-pyrroline (LNP 911), a High-Affinity Radioligand Selective for I1Imidazoline Receptors
2002
·
Hugues Greney
, Dragan Urosevic
, et al.
·
Molecular Pharmacology
·
25
I1 imidazoline receptor-mediated effects on apoptotic processes in PC12 cells
2004
·
L Dupuy
, D Urosevic
, et al.
·
Cell Death and Differentiation
·
24
PDF
Efficacy and tolerability of taspoglutide versus pioglitazone in subjects with type 2 diabetes uncontrolled with sulphonylurea or sulphonylurea‐metformin therapy: a randomized, double‐blind study (T‐emerge 6)
2012
·
R. E. Pratley
, D. Urosevic
, et al.
·
Diabetes Obesity and Metabolism
·
22
LNP 906, the first high‐affinity photoaffinity ligand selective for I1 imidazoline receptors
2004
·
Urosevic Dragan
, Schann Stephan
, et al.
·
British Journal of Pharmacology
·
21
PDF
EFFICACY AND SAFETY OF THE PROPOSED BIOSIMILAR AFLIBERCEPT, SDZ-AFL, IN PATIENTS WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: 52-Week Results From the Phase 3 Mylight Study
2024
·
Arnaldo F. Bordon
, Peter K. Kaiser
, et al.
·
Retina
·
18
LNP 906, the first high‐affinity photoaffinity ligand selective for I1 imidazoline receptors
2004
·
Dragan Urosevic
, Stephan Schann
, et al.
·
British Journal of Pharmacology
·
14
PDF
G-Protein inwardly rectifying potassium channels are involved in the hypotensive effect of I1-imidazoline receptor selective ligands
2008
·
Guata Yoro Sy
, Dragan Urosevic
, et al.
·
Journal of Hypertension
·
13
Safety and Effectiveness of a Biosimilar Recombinant Human Growth Hormone in Children Requiring Growth Hormone Treatment: Analysis of Final Data from PATRO Children, an International, Post-Marketing Surveillance Study
2024
·
Sandro Loche
, Shankar Kanumakala
, et al.
·
Drug Design Development and Therapy
·
12
PDF
Safety and effectiveness of replacement with biosimilar growth hormone in adults with growth hormone deficiency: results from an international, post-marketing surveillance study (PATRO Adults)
2021
·
Charlotte Höybye
, Paolo Beck-Peccoz
, et al.
·
Pituitary
·
3
PDF
Development of Biosimilar Aflibercept SDZ-AFL
2025
·
Francis Dodeller
, Peter Alliger
, et al.
·
Current Therapeutic Research
·
2
Girk channels are involved in the hypotensive effect of I1 imidazoline receptor selective ligands
2007
·
Pascal Bousquet
, Guata Yoro Sy
, et al.
·
Autonomic Neuroscience
·
1
EFFICACY AND SAFETY OF THE PROPOSED BIOSIMILAR AFLIBERCEPT, SDZ-AFL, IN PATIENTS WITH NEOVASCULAR AGE-RELATED MACULAR DEGENERATION: 52-Week Results From the Phase 3 Mylight Study: Erratum
2026
·
Arnaldo F. Bordon
, Peter K. Kaiser
, et al.
·
Retina
Safety and Effectiveness of a Biosimilar Recombinant Growth Hormone in Adults with Growth Hormone Deficiency: Analysis of Final Data from PATRO Adults, an International Post-Marketing Surveillance Study
2024
·
Paolo Beck-Peccoz
, Charlotte Höybye
, et al.
·
Drug Design Development and Therapy
P2–383: Visualizing the mGlu5 receptor in a human PET–study
2006
·
Uta C. Fischer
, Valerie Treyer
, et al.
·
Alzheimer s & Dementia
PDF
Caractérisation moléculaire du récepteur des imidazolines I1 par l'utilisation de ligands sélectifs radioactifs et de photoaffinité
2004
·
Dragan Urosevic
·
OpenGrey (Institut de l'Information Scientifique et Technique)
Show more works
View as search
Works count:
16
Citation count:
189
H-index:
9
I10-index:
9
Year
Topic
Type